| Stereotactic body radiotherapy plus rucosopasem in locally advanced or borderline resectable pancreatic cancer: GRECO-2 phase II study design SE Hoffe, TA Aguilera, PJ Parikh, MM Ghaly, JM Herman, JM Caster, ... Future Oncology 20 (8), 437-446, 2024 | | 2024 |
| 755 DEKA-1 a dose-finding Phase 1 trial: observing safety and biomarkers using DK210 (EGFR) for inoperable locally advanced and/or metastatic EGFR+ tumors failing systemic therapy AI Spira, D Orr, A Marabelle, EC Moser, D Kientop, J Mumm Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
| 718TiP DEKA-1 a dose-finding phase I trial: Observing safety and biomarkers using DK210 (EGFR) for inoperable locally advanced and/or metastatic EGFR+ tumors with progressive … E Moser, M Salkeni, A Marabelle, D Kientop, J Mumm Annals of Oncology 34, S496, 2023 | | 2023 |
| Greco-2: A randomized, phase 2 study of stereotactic body radiation therapy (SBRT) in combination with rucosopasem (GC4711) in the treatment of locally advanced or borderline … TA Aguilera, P Parikh, M Ghaly, SE Hoffe, JM Herman, JM Caster, ... Journal of Clinical Oncology 41 (4_suppl), TPS766-TPS766, 2023 | | 2023 |
| GRECO-1: Phase 1/2 Study of Stereotactic Body Radiation Therapy (SBRT) with or without Rucosopasem (GC4711) for Early Stage, Peripheral or Centrally Located Non-Small Cell Lung … P Iyengar, BG Allen, CR Kelsey, EC Moser, M Holm, M Kurman, ... International Journal of Radiation Oncology, Biology, Physics 114 (3), e375-e376, 2022 | | 2022 |
| PredictCARE: personalized complication risk prediction tool EC Moser, G Nayaran Approaching Global Oncology: The win-win model, 25-1-25-5, 2022 | | 2022 |
| GRECO-2: A randomized, phase 2 study of stereotactic body radiation therapy (SBRT) in combination with rucosopasem (GC4711) in the treatment of locally advanced or borderline … SE Hoffe, DW Kim, J Costello, MP Malafa, TA Aguilera, SS Beg, P Parikh, ... Journal of Clinical Oncology 40 (16_suppl), TPS4184-TPS4184, 2022 | | 2022 |
| GRECO-1: Phase 1/2 Study of Stereotactic Body Radiation Therapy (SBRT) With or Without GC4711 for Early Stage, Centrally Located or Large Non-Small Cell Lung Cancer (NSCLC) P Iyengar, BG Allen, CR Kelsey, J Holmlund, M Brookes, EC Moser International Journal of Radiation Oncology, Biology, Physics 111 (3), e471, 2021 | | 2021 |
| GRECO-2: a randomized, phase 2 study of stereotactic body radiation therapy (SBRT) in combination with GC4711 in the treatment of unresectable or borderline resectable … S Hoffe, DW Kim, M Malafa, J Costello, TA Aguilera, SM Beg, PJ Parikh, ... International journal of radiation oncology, biology, physics 111 (3), e44-e45, 2021 | 3 | 2021 |
| The impact of isolated local recurrence on long-term outcome in early-breast cancer patients after breast-conserving therapy C Vrieling, SY Assele, L Moser, N Sauve, S Litière, A Fourquet, ... European Journal of Cancer 155, 28-37, 2021 | 4 | 2021 |
| Breast Cancer Management and Coordination Using Artificial Intelligence EC Moser EC Gynaecology 10, 71-83, 2021 | | 2021 |
| Randomized, double-blinded, placebo-controlled multicenter adaptive phase 1-2 trial of GC 4419, a dismutase mimetic, in combination with high dose stereotactic body radiation … S Hoffe, JM Frakes, TA Aguilera, B Czito, M Palta, M Brookes, ... International journal of radiation oncology, biology, physics 108 (5), 1399-1400, 2020 | 13 | 2020 |
| Adaptive dose optimization trial of stereotactic body radiation therapy (SBRT) with or without GC4419 (avasopasem manganese) in pancreatic cancer. EC Moser, SE Hoffe, J Frakes, TA Aguilera, M Karim, LE Colbert, ... Journal of Clinical Oncology 38 (15_suppl), TPS4670-TPS4670, 2020 | 2 | 2020 |
| Improving breast cancer care coordination and symptom management by using AI driven predictive toolkits EC Moser, G Narayan The Breast 50, 25-29, 2020 | 28 | 2020 |
| Cardiac disease and lifestyle risk factors following hodgkin lymphoma: An eortc lymphoma group and gela follow-up study MV Maraldo, F Giusti, M Van Der Kaaij, M Henry-Amar, B Aleman, ... International Journal of Radiation Oncology, Biology, Physics 99 (2), S139-S140, 2017 | 1 | 2017 |
| Cardiac disease prediction following Hodgkin lymphoma: An EORTC Lymphoma Group and GELA follow-up study MV Maraldo, F Giusti, MAE van der Kaaij, M Henry-Amar, BMP Aleman, ... Hematological Oncology 35, 174-174, 2017 | | 2017 |
| P029 (0142) QUALITY ASSURANCE OF INVOLVED-NODE RADIOTHERAPY: FIRST RESULTS OF THE HD17-TRIAL OF THE GHSG J Kriz, C Baues, M Oertel, R Engenhart-Cabillic, K Herfarth, P Lukas, ... chemotherapy 2012, 330, 2017 | 3 | 2017 |
| Cancer in Europe: Death sentence or life sentence? L Liu, P O'Donnell, R Sullivan, A Katalinic, EC Moser, A de Boer, ... European journal of cancer 65, 150-155, 2016 | 24 | 2016 |
| EORTC breast cancer survivorship project: First analysis of 3 large early breast cancer radiotherapy trials C Vrieling, L Moser, L Collette, J Bogaerts, S Collette, S Litiere, L Slaets, ... EUROPEAN JOURNAL OF CANCER 57, S47-S48, 2016 | | 2016 |
| Second international consensus guidelines for breast cancer in young women (BCY2) S Paluch-Shimon, O Pagani, AH Partridge, E Bar-Meir, L Fallowfield, ... The Breast 26, 87-99, 2016 | 147 | 2016 |
Lena SpechtProfessor i onkologi, Københavns Universitet在 regionh.dk 的电子邮件经过验证
